Article
In vivo inactivation of RAD51-mediated homologous recombination leads to premature aging…
bioRxiv · 2022 · Gabriel Matos-Rodrigues
Key facts
| Title | In vivo inactivation of RAD51-mediated homologous recombination leads to premature aging, but not to tumorigenesis |
|---|---|
| First author | Gabriel Matos-Rodrigues |
| Journal | bioRxiv |
| Published | Jan 17, 2022 |
| DOI | 10.1101/2022.01.17.476609 |
| Devices mentioned | K011853, K042152, K781043, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840 and 26 more |
| Product codes mentioned | CFN, DFZ, DHR, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF and 5 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1